Currently holds a position at United Therapeutics Corp
Position | Company | Period |
---|---|---|
Chairman of the Board, Chief Executive Officer | United Therapeutics Corp | June 26, 2016 - |
Chairman of the Board, Co-Chief Executive Officer | United Therapeutics Corp | Dec. 1, 2014 - June 26, 2016 |
Chairman of the Board, Chief Executive Officer | United Therapeutics Corp | Jan. 1, 1996 - Dec. 1, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-05-14 | 2024-05-13 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
180
-58.1%
268.8948,399 USD |
180 -58.1% | 268.89 | 48,399 USD | |
2024-05-14 | 2024-05-13 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
251
-44.7%
267.8467,228 USD |
251 -44.7% | 267.84 | 67,228 USD | |
2024-05-14 | 2024-05-13 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
647
-53.6%
266.56172,463 USD |
647 -53.6% | 266.56 | 172,463 USD | |
2024-05-14 | 2024-05-13 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
850
-41.3%
265.40225,589 USD |
850 -41.3% | 265.40 | 225,589 USD | |
2024-05-14 | 2024-05-13 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,672
-44.8%
264.39442,064 USD |
1,672 -44.8% | 264.39 | 442,064 USD | |
2024-05-14 | 2024-05-10 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
114
-46.7%
269.1330,681 USD |
114 -46.7% | 269.13 | 30,681 USD | |
2024-05-14 | 2024-05-10 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
224
-47.9%
268.1060,054 USD |
224 -47.9% | 268.10 | 60,054 USD | |
2024-05-14 | 2024-05-10 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
619
-56.9%
267.02165,284 USD |
619 -56.9% | 267.02 | 165,284 USD | |
2024-05-14 | 2024-05-10 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
894
-45.1%
265.40237,267 USD |
894 -45.1% | 265.40 | 237,267 USD | |
2024-05-14 | 2024-05-10 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,749
-46.9%
264.44462,502 USD |
1,749 -46.9% | 264.44 | 462,502 USD | |
2024-05-10 | 2024-05-09 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
682
-84.0%
265.82181,286 USD |
682 -84.0% | 265.82 | 181,286 USD | |
2024-05-10 | 2024-05-09 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
682
-84.0%
265.82181,286 USD |
682 -84.0% | 265.82 | 181,286 USD | |
2024-05-10 | 2024-05-09 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,103
-57.6%
265.21292,530 USD |
1,103 -57.6% | 265.21 | 292,530 USD | |
2024-05-10 | 2024-05-09 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,103
-57.6%
265.21292,530 USD |
1,103 -57.6% | 265.21 | 292,530 USD | |
2024-05-10 | 2024-05-09 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
562
-22.7%
263.98148,356 USD |
562 -22.7% | 263.98 | 148,356 USD | |
2024-05-10 | 2024-05-09 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
562
-22.7%
263.98148,356 USD |
562 -22.7% | 263.98 | 148,356 USD | |
2024-05-10 | 2024-05-09 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,006
-28.9%
262.79264,362 USD |
1,006 -28.9% | 262.79 | 264,362 USD | |
2024-05-10 | 2024-05-09 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,006
-28.9%
262.79264,362 USD |
1,006 -28.9% | 262.79 | 264,362 USD | |
2024-05-10 | 2024-05-09 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
247
-6.6%
261.8364,673 USD |
247 -6.6% | 261.83 | 64,673 USD | |
2024-05-10 | 2024-05-09 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
247
-6.6%
261.8364,673 USD |
247 -6.6% | 261.83 | 64,673 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
29
-18.2%
268.307,781 USD |
29 -18.2% | 268.30 | 7,781 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
29
-18.2%
268.307,781 USD |
29 -18.2% | 268.30 | 7,781 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
253
-61.4%
266.5867,445 USD |
253 -61.4% | 266.58 | 67,445 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
253
-61.4%
266.5867,445 USD |
253 -61.4% | 266.58 | 67,445 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
113
-21.5%
266.1030,069 USD |
113 -21.5% | 266.10 | 30,069 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
113
-21.5%
266.1030,069 USD |
113 -21.5% | 266.10 | 30,069 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
713
-57.6%
264.75188,764 USD |
713 -57.6% | 264.75 | 188,764 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
713
-57.6%
264.75188,764 USD |
713 -57.6% | 264.75 | 188,764 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
223
-15.3%
263.1058,671 USD |
223 -15.3% | 263.10 | 58,671 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
223
-15.3%
263.1058,671 USD |
223 -15.3% | 263.10 | 58,671 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,430
-49.5%
262.38375,204 USD |
1,430 -49.5% | 262.38 | 375,204 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,430
-49.5%
262.38375,204 USD |
1,430 -49.5% | 262.38 | 375,204 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
839
-22.5%
261.33219,253 USD |
839 -22.5% | 261.33 | 219,253 USD | |
2024-05-10 | 2024-05-08 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
839
-22.5%
261.33219,253 USD |
839 -22.5% | 261.33 | 219,253 USD | |
2024-05-08 | 2024-05-07 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
811
-86.2%
266.13215,828 USD |
811 -86.2% | 266.13 | 215,828 USD | |
2024-05-08 | 2024-05-07 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
315
-25.1%
264.9183,446 USD |
315 -25.1% | 264.91 | 83,446 USD | |
2024-05-08 | 2024-05-07 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
927
-42.5%
263.97244,702 USD |
927 -42.5% | 263.97 | 244,702 USD | |
2024-05-08 | 2024-05-07 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
930
-29.9%
262.73244,334 USD |
930 -29.9% | 262.73 | 244,334 USD | |
2024-05-08 | 2024-05-07 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
617
-16.5%
261.63161,427 USD |
617 -16.5% | 261.63 | 161,427 USD | |
2024-05-07 | 2024-05-06 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
142
-52.2%
264.1437,508 USD |
142 -52.2% | 264.14 | 37,508 USD | |
2024-05-07 | 2024-05-06 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
4
-1.4%
261.941,048 USD |
4 -1.4% | 261.94 | 1,048 USD | |
2024-05-07 | 2024-05-06 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
157
-36.3%
261.5141,057 USD |
157 -36.3% | 261.51 | 41,057 USD | |
2024-05-07 | 2024-05-06 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,982
-82.1%
260.28515,875 USD |
1,982 -82.1% | 260.28 | 515,875 USD | |
2024-05-07 | 2024-05-06 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
599
-19.9%
259.15155,229 USD |
599 -19.9% | 259.15 | 155,229 USD | |
2024-05-07 | 2024-05-06 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
496
-14.1%
257.70127,817 USD |
496 -14.1% | 257.70 | 127,817 USD | |
2024-05-07 | 2024-05-06 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
220
-5.9%
256.3556,397 USD |
220 -5.9% | 256.35 | 56,397 USD | |
2024-05-07 | 2024-05-03 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
222
-63.1%
262.3358,237 USD |
222 -63.1% | 262.33 | 58,237 USD | |
2024-05-07 | 2024-05-03 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,191
-77.2%
261.51311,456 USD |
1,191 -77.2% | 261.51 | 311,456 USD | |
2024-05-07 | 2024-05-03 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
574
-27.1%
260.43149,485 USD |
574 -27.1% | 260.43 | 149,485 USD | |
2024-05-07 | 2024-05-03 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
799
-27.4%
259.11207,025 USD |
799 -27.4% | 259.11 | 207,025 USD | |
2024-05-07 | 2024-05-03 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
699
-19.3%
258.24180,512 USD |
699 -19.3% | 258.24 | 180,512 USD | |
2024-05-07 | 2024-05-03 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
115
-3.1%
257.3029,589 USD |
115 -3.1% | 257.30 | 29,589 USD | |
2024-05-03 | 2024-05-02 |
United Therapeutics Corp
(UTHR)
|
S Sale |
273
-67.7%
259.8070,925 USD |
273 -67.7% | 259.80 | 70,925 USD | |
2024-05-03 | 2024-05-02 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,373
-77.3%
259.12355,769 USD |
1,373 -77.3% | 259.12 | 355,769 USD | |
2024-05-03 | 2024-05-02 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,203
-40.4%
258.11310,505 USD |
1,203 -40.4% | 258.11 | 310,505 USD | |
2024-05-03 | 2024-05-02 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
296
-9.0%
256.1775,827 USD |
296 -9.0% | 256.17 | 75,827 USD | |
2024-05-03 | 2024-05-02 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
264
-7.5%
255.6267,483 USD |
264 -7.5% | 255.62 | 67,483 USD | |
2024-05-03 | 2024-05-02 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
191
-5.1%
254.4548,599 USD |
191 -5.1% | 254.45 | 48,599 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
26
-16.7%
257.556,696 USD |
26 -16.7% | 257.55 | 6,696 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
95
-37.8%
256.1324,332 USD |
95 -37.8% | 256.13 | 24,332 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
558
-69.0%
254.99142,282 USD |
558 -69.0% | 254.99 | 142,282 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
610
-43.0%
254.07154,980 USD |
610 -43.0% | 254.07 | 154,980 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
307
-17.8%
252.9177,642 USD |
307 -17.8% | 252.91 | 77,642 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
501
-22.5%
251.54126,024 USD |
501 -22.5% | 251.54 | 126,024 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
208
-8.5%
250.3352,069 USD |
208 -8.5% | 250.33 | 52,069 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
291
-10.7%
248.7872,394 USD |
291 -10.7% | 248.78 | 72,394 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
231
-7.8%
247.3657,139 USD |
231 -7.8% | 247.36 | 57,139 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
186
-5.9%
245.2645,619 USD |
186 -5.9% | 245.26 | 45,619 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
246
-7.3%
243.4459,886 USD |
246 -7.3% | 243.44 | 59,886 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
103
-2.9%
242.7925,007 USD |
103 -2.9% | 242.79 | 25,007 USD | |
2024-05-03 | 2024-05-01 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
238
-6.4%
238.3356,723 USD |
238 -6.4% | 238.33 | 56,723 USD | |
2024-05-01 | 2024-04-30 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
251
-65.9%
236.3759,329 USD |
251 -65.9% | 236.37 | 59,329 USD | |
2024-05-01 | 2024-04-30 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
2,349
-86.0%
235.52553,236 USD |
2,349 -86.0% | 235.52 | 553,236 USD | |
2024-05-01 | 2024-04-30 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
1,000
-26.8%
234.71234,712 USD |
1,000 -26.8% | 234.71 | 234,712 USD | |
2024-05-01 | 2024-04-29 |
United Therapeutics Corp
(UTHR)
|
PS Planned sale |
253
-66.1%
240.5560,859 USD |
253 -66.1% | 240.55 | 60,859 USD |